Top therapeutic area for FDA 2026 approvals?

Market trust

Review trustProviderManual ReviewEvidenceNot Ready

Manual source - last checked Not checked yet

Trust score: In review
Source type: Manual
Provider health: Manual Review
Criteria quality: Warn
Market data quality: Review
Public evidence state: Not Ready
Chart data provenance: Drazill Market Data
Price history freshness: Fresh
Last source check: Not checked yet

Trust methodology

Formula: market-trust-v1.0

Window: Latest market, criteria, provider, and evidence records

Confidence: MEDIUM

Informational only, not trading advice.

- Provider health is market-specific when resolution checks exist and otherwise inferred from configuration.
- Manual-only markets rely on admin review rather than automated source polling.

Trusted creator with 1277 approved markets

Outcome

Chance

Trade

About This Market

Predicts the leading category among 2026 novel FDA drug approvals. Resolves to the area with the most novel approvals by year-end. Source: FDA CDER novel-approvals report.

Source

Official announcement or authoritative source

Market open

May 17, 2026, 03:26 p.m.

Market closes

Jan 8, 2027, 02:26 p.m.

Projected payout

After market closes

Top therapeutic area for FDA 2026 approvals?

Market trust

About This Market

Related Markets

Top therapeutic area for FDA 2026 approvals?

Market trust

About This Market

Other

Related Markets

Other